Movie S1. Showing the development of MitoSOX red fluorescence in DMSO-treated MCF-7 cells. (AVI 9250 kb
Figure S2. Chloroquine and bortezomib inhibition of lysosome and proteasome activity. (DOCX 1074âk...
Table S3. Differentially expressed genes in MCF-7 cells treated with DMOG comparing to the ones trea...
Figure S3. Partial prevention of ischemic-like-cell-death morphological changes by NAD+. Bars indica...
Movie S2. Showing the development of MitoSOX red fluorescence in 1,25(OH)2D3-treated MCF-7 cells. (A...
Figure S1. 1,25(OH)2D3 (100 nM) significantly reduces glucose uptake in MCF-7 cells after 24, but no...
Figure S2 Cell viability of the MCF-10A human breast epithelial cell line after 3âdays of treatmen...
Figure S5 Cell viability of treated MCF-7 cells was evaluated by LDH release assay on days (d) 1, 3,...
Figure S2. MASTL depletion increases G2 arrest and the accumulation of pH 3. a The quantification of...
Figure S3 Expression of 8-hydroxydeoxyguanosine (8-OHdG) in breast tumours. Twenty days after the in...
Is Movie S3 showing collective invasion of control 4T1 cells that express considerable endogenous po...
Flow cytometry analysis of CD14 + cells differentiated for 5 days with or without 50 % conditioned m...
Figure S2. Stable knockdown of FTO in breast cancer cells by lentiviral shRNA sequences (shFTO#1 and...
Table S2. Differentially expressed genes in FTO-knockdown MDA-MB-231 cells. (XLSX 764 kb
Figure S1. Gene expression in breast cancer. a Volcano plot of gene expression changes in the transc...
IFNβ pre-treatment protects EMT6, 4 T1 and EO771 cells from virus-mediated killing. Coomassie Blue s...
Figure S2. Chloroquine and bortezomib inhibition of lysosome and proteasome activity. (DOCX 1074âk...
Table S3. Differentially expressed genes in MCF-7 cells treated with DMOG comparing to the ones trea...
Figure S3. Partial prevention of ischemic-like-cell-death morphological changes by NAD+. Bars indica...
Movie S2. Showing the development of MitoSOX red fluorescence in 1,25(OH)2D3-treated MCF-7 cells. (A...
Figure S1. 1,25(OH)2D3 (100 nM) significantly reduces glucose uptake in MCF-7 cells after 24, but no...
Figure S2 Cell viability of the MCF-10A human breast epithelial cell line after 3âdays of treatmen...
Figure S5 Cell viability of treated MCF-7 cells was evaluated by LDH release assay on days (d) 1, 3,...
Figure S2. MASTL depletion increases G2 arrest and the accumulation of pH 3. a The quantification of...
Figure S3 Expression of 8-hydroxydeoxyguanosine (8-OHdG) in breast tumours. Twenty days after the in...
Is Movie S3 showing collective invasion of control 4T1 cells that express considerable endogenous po...
Flow cytometry analysis of CD14 + cells differentiated for 5 days with or without 50 % conditioned m...
Figure S2. Stable knockdown of FTO in breast cancer cells by lentiviral shRNA sequences (shFTO#1 and...
Table S2. Differentially expressed genes in FTO-knockdown MDA-MB-231 cells. (XLSX 764 kb
Figure S1. Gene expression in breast cancer. a Volcano plot of gene expression changes in the transc...
IFNβ pre-treatment protects EMT6, 4 T1 and EO771 cells from virus-mediated killing. Coomassie Blue s...
Figure S2. Chloroquine and bortezomib inhibition of lysosome and proteasome activity. (DOCX 1074âk...
Table S3. Differentially expressed genes in MCF-7 cells treated with DMOG comparing to the ones trea...
Figure S3. Partial prevention of ischemic-like-cell-death morphological changes by NAD+. Bars indica...
DOI
Add to ORKG